Cargando…
24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]
BACKGROUND: Early studies with desloratadine demonstrated efficacy in treating seasonal allergic rhinitis (SAR). A dose-ranging study was conducted to characterize its 24-hour efficacy in patients with SAR. METHODS: Patients (N = 1,026) were randomly assigned once-daily (QD) desloratadine (2.5, 5, 7...
Autores principales: | Salmun, Luis M, Lorber, Richard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC122063/ https://www.ncbi.nlm.nih.gov/pubmed/12162793 http://dx.doi.org/10.1186/1471-2296-3-14 |
Ejemplares similares
-
Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971].
por: Haye, Rolf, et al.
Publicado: (2005) -
Treating allergic conjunctivitis: A once-daily medication that provides 24-hour symptom relief
por: Carr, Warner, et al.
Publicado: (2016) -
Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
por: Nettis, E, et al.
Publicado: (2008) -
The 24-Hour Cardiac Autonomic Activity in Patients With Allergic Rhinitis
por: Won, Jun Yeon, et al.
Publicado: (2023) -
Efficacy and Safety of Once Daily Fluticasone Furoate Nasal Spray for Treatment of Irritant (Non-allergic) Rhinitis
por: Tantilipikorn, Pongsakorn, et al.
Publicado: (2010)